Emerson (EMR) Q4 2026 (USD): Adj. EPS 1.86 (exp. 1.85), Sales 5.2bln (exp. 5.11bln)
ORIGINAL · NewsquawkEmerson (EMR) Q4 2026 (USD): Adj. EPS 1.86 (exp. 1.85), Sales 5.2bln (exp. 5.11bln)Read originalHide original
Other quarterly metrics Pretax profit 997mln FCF 916mln. Operating cash flow 1.08bln. Q1 FY27 guidance: Adj. EPS 1.58-1.62 (exp. 1.62), Sales growth 5%, Adj. sales growth 5%. FY27 guidance: Adj EPS 7.25 (exp. 7.27).
Emerson reported Q4 adjusted EPS of $1.86 and $5.2 billion in sales. Retrieved accounts report Q1 and FY2027 EPS guidance, with different sales-estimate figures.
News detail
Other quarterly metrics Pretax profit 997mln FCF 916mln. Operating cash flow 1.08bln. Q1 FY27 guidance: Adj. EPS 1.58-1.62 (exp. 1.62), Sales growth 5%, Adj. sales growth 5%. FY27 guidance: Adj EPS 7.25 (exp. 7.27).
Related stocks
1 stocksWhat do investors think?
StockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.
